Department of Ophthalmology, Saneikai Tsukazaki Hospital, 68-1 Aboshi-ku, Waku, Himeji, Hyogo, 671-1227, Japan.
Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, 36-1 Nishicho, Yonago, Tottori, 683-8504, Japan.
Adv Ther. 2022 Dec;39(12):5568-5581. doi: 10.1007/s12325-022-02324-w. Epub 2022 Oct 16.
Topical antihistamines are often instilled symptomatically to control patients' eye allergy symptoms. The purpose of this study was to evaluate the effectiveness of proactive and as-needed use of antihistamine eye drops in controlling symptoms and to examine whether proactive use may improve quality of life (QOL).
This was a prospective, multicenter, cohort study in Japan. We classified 418 patients who had developed certain symptoms and used antihistamine eye drops for 2 weeks into two groups: those who used the drops at the required frequency at a fixed time (proactive use) and those who used them as-needed. The Japanese Allergic and Conjunctival Diseases Quality of Life Questionnaire (JACQLQ) and Ten-Item Personality Inventory were used to evaluate QOL and personality. Participants' QOL was evaluated using JACQLQ scores after matching of baseline characteristics using propensity score analysis.
After propensity score matching, 115 "proactive" and 115 "as-needed" patients were analyzed. After treatment, in "as-needed" patients, the overall QOL scale was 1.66 (95% CI 1.55-1.78); in "proactive" patients, the overall QOL scale was 1.34 (95% CI 1.23-1.46) and was significantly improved compared with the "as-needed" patients (analysis of covariance, P = 0.002). Furthermore, proactive use significantly alleviated depression (P = 0.03). This improvement of QOL was independent of improvement of the clinical sign scores.
Proactive use of topical antihistamine may serve as an effective means for improving QOL of patients with seasonal allergic conjunctivitis.
University Hospital Medical Information Network (UMIN) 000039554.
局部抗组胺药常被用于对症治疗以控制患者的眼部过敏症状。本研究旨在评估有症状地使用和按需使用抗组胺滴眼剂控制症状的有效性,并探讨有症状地使用是否可以提高生活质量(QOL)。
这是一项在日本进行的前瞻性、多中心、队列研究。我们将 418 名出现特定症状并使用抗组胺滴眼剂治疗 2 周的患者分为两组:按时按需使用滴眼剂(主动使用)和按需使用。使用日本过敏性和结膜疾病生活质量问卷(JACQLQ)和十项人格量表评估 QOL 和人格。使用倾向评分分析匹配基线特征后,使用 JACQLQ 评分评估参与者的 QOL。
在进行倾向评分匹配后,分析了 115 名“主动”和 115 名“按需”患者。治疗后,在“按需”患者中,总体 QOL 量表得分为 1.66(95%置信区间 1.55-1.78);在“主动”患者中,总体 QOL 量表得分为 1.34(95%置信区间 1.23-1.46),与“按需”患者相比显著改善(协方差分析,P=0.002)。此外,主动使用可显著缓解抑郁(P=0.03)。这种 QOL 的改善与临床体征评分的改善无关。
局部抗组胺药的主动使用可能是改善季节性过敏性结膜炎患者 QOL 的有效方法。
大学医院医学信息网络(UMIN)000039554。